Anemia Drugs May Not Be Safe At Low Levels: FDA

By Sam Schulz

Law360 (November 9, 2007, 12:00 AM EST) -- The Food and Drug Administration has toughened its black-box warnings on three Amgen Inc. anemia drugs, warning patients that not only could high doses of the drug increase their risk of...

To view the full article, register now.

Try Law360 FREE for seven days

Already a subscriber? Click here to login

Add to Briefcase
Printable Version
Rights/Reprints
Editorial Contacts

Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.

Listen To Our Latest

Anemia Drugs May Not Be Safe At Low Levels: FDA

Related

Sections

Companies

Government Agencies

Most Popular

Show all interests